Clinical data have also shown that the cytosine-adenine repeat genotype in the ERβ gene (ESR2) and resultant ERβ expression levels, along with estrogen activation, may influence MMR status in CRC [46]. The gene discussed is ESR2; the disease is colorectal carcinoma.